Two-year outcomes comparing Embosphere® microspheres versus Imipenem Cilastatin for genicular artery embolization in patients with moderate to severe knee osteoarthritis

Author:

Bhatia Shivank,Jalaeian Hamed,Kumar Jessica,Acharya Vedant,Shibuya Masahiko,Bhatia Ansh,Okuno Yuji

Publisher

Elsevier BV

Subject

Orthopedics and Sports Medicine

Reference25 articles.

1. The epidemiology and impact of pain in osteoarthritis;Neogi;Osteoarthritis Cartilage,2013

2. Genicular Artery Embolization for Osteoarthritis Related Knee Pain: A Systematic Review and Qualitative Analysis of Clinical Outcomes;Casadaban;Cardiovasc Intervent Radiol,2021

3. Current Concepts and Future Directions of Minimally Invasive Treatment for Knee Pain;Goldman;Curr Rheumatol Rep,2018

4. Midterm Clinical Outcomes and MR Imaging Changes after Transcatheter Arterial Embolization as a Treatment for Mild to Moderate Radiographic Knee Osteoarthritis Resistant to Conservative Treatment;Okuno;J Vasc Interv Radiol,2017

5. Merit Medical Receives FDA “Breakthrough Device Designation” for Embosphere® Microspheres for Use in Genicular Artery Embolization for Symptomatic Knee Osteoarthritis [Internet]. Merit Medical. [cited 2022 May 7]. Available from: https://www.merit.com/press-release/merit-medical-receives-fda-breakthrough-device-designation-for-embosphere-microspheres-for-use-in-genicular-artery-embolization-for-symptomatic-knee-osteoarthritis/.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3